MedTrace Logo

PDS*Plus and Wound Infections After Laparotomy

NCT00998907 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1042

Last updated 2012-01-18

No results posted yet for this study

Summary

The aim of this study is to ascertain if the use of PDS plus® reduces the number of wound infections and incisional hernia after midline and transverse laparotomy comparing to polyglactin suture.

Conditions

  • Wound Infection
  • Incisional Hernia

Interventions

DEVICE

PDS plus

triclosan-coated polydiaxanon 910 suture materials with antiseptic activity (PDS plus®, Ethicon GmbH, Norderstedt, Germany)

DEVICE

PDS II

polyglactin 910 suture material for abdominal wall closure

Sponsors & Collaborators

  • University Hospital, Saarland

    lead OTHER

Principal Investigators

  • Christoph Justinger, M.D. · Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, D-66421 Homburg/Saar, Germany

  • Martin K Schilling, M.D., FRCS · Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, D-66421 Homburg/Saar, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-11-30
Completion
2012-01-31

Countries

  • Germany

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00998907 on ClinicalTrials.gov